Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Aurinia Pharmaceuticals Inc - Common Shares (NQ:AUPH)

13.97 -0.46 (-3.19%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Aurinia Pharmaceuticals Inc - Common Shares

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
News headline image
Cramer Advises Viewers On Palantir, SoFi And More ↗
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't understand why is MKS Instruments, Inc. (NASDAQ: MKSI) trading so cheap. He would be a buyer.... 
Via Benzinga
Analyzing Aurinia Pharmaceuticals's Unusual Options Activity ↗
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced ... 
Via Benzinga
News headline image
62 Biggest Movers From Yesterday ↗
Gainers Flora Growth Corp. (NASDAQ: FLGC) surged 63.1% to close at $8.27. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to... 
Via Benzinga
Topics Cannabis
News headline image
Understanding Aurinia Pharmaceuticals's Unusual Options Activity ↗
On Wednesday, shares of Aurinia Pharmaceuticals (NASDAQ:AUPH) saw unusual options activity. After the option alert, the stock price moved up to $12.55. Sentiment: BULLISH Option... 
Via Benzinga
News headline image
Banned Merger ↗
Today stock markets are in disarray after the full horror of Beijing's attack on Chinese capitalism has been understood. 
Via Talk Markets
News headline image
Aurinia Pharmaceuticals to Release Second Quarter 2021 Financial Results on August 5, 2021
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Awards $250,000 in Grants to Support Patient Navigation Programs
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Announces Licensing Partner Otsuka Filed Initial Marketing Authorization Application (MAA) for Voclosporin with the European Medicines Agency (EMA)
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Reconsidered Boom ↗
The US markets tried to repeat the big rise from yesterday, and appears to have succeeded. 
Via Talk Markets
News headline image
The First Day Of Summer And Prime Day ↗
The bull is back in business today. 
Via Talk Markets
News headline image
Two Rate Hikes In 2023 ↗
This afternoon our Fed chief Jerome Powell predicted there will be interest rate hikes faster than before. The news hit US stocks, gold, and bitcoin hard. 
Via Talk Markets
Topics Economy
News headline image
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Wednesday News And Catch-Up ↗
Today the US market resumed its attempt to hit a new record for the S&P 500 and Nasdaq, but not the DJIA. 
Via Talk Markets
Topics Stocks
News headline image
Aurinia Announces Results of the 2021 Annual General Meeting
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia Announces Additional Analysis of its AURORA 1 Phase 3 Study Data Presented at ERA-EDTA 2021 Congress
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Fan Hit ↗
The 10-yr US treasury yield rose to 1.6% again. Later in the day, a rally was attempted, mostly for the meme shares. 
Via Talk Markets
News headline image
Unusual Options Activity Insight: Aurinia Pharmaceuticals ↗
Aurinia Pharmaceuticals (NASDAQ:AUPH) shares experienced unusual options activity on Thursday. The stock price moved down to $13.6 following the option alert. Sentiment: BEARISH... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Nod For Novartis, iRhythm CEO Quits Abruptly, Moderna Inks Vaccine Supply Agreements ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 1) Anika Therapeutics, Inc. (... 
Via Benzinga
News headline image
The Week Ahead In Biotech: ASCO Presentations Front And Center, FDA Decisions Due For Scynexis, Liminal And Alkermes ↗
After having declined through the first half of the week, biotech stocks staged a recovery to close higher in the trading week ended May 28. Broader market sentiment and company-... 
Via Benzinga
News headline image
Aurinia Pharmaceuticals to Present at the Jefferies Virtual Healthcare Conference
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Aurinia's Lupkynis Shows Sustained Renal Response Rates In Lupus Nephritis Patients ↗
Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has announced a supportive interim analysis of its AURORA 2 continuation study evaluating Lupkynis (voclosporin) in... 
Via Benzinga
News headline image
Aurinia To Present Supportive AURORA 2 Continuation Study Interim Analysis Demonstrating Long-Term Safety & Efficacy of LUPKYNIS™ (voclosporin) in Subjects with Lupus Nephritis
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
2 Grossly Undervalued Biotech Stocks That Could Double Your Money ↗
Aurinia Pharmaceuticals and Agenus might be poised for a healthy growth spurt. 
Via The Motley Fool
News headline image
Another Tough Day For Markets ↗
The stock market resumed its negativism today mainly linked to fear of inflation and higher interest rates, on the argument that the most dangerous thing to believe is “it's different this time.” 
Via Talk Markets
News headline image
Aurinia Pharmaceuticals to Participate in Two Upcoming Investor Conferences
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
Heavy Global Erosion ↗
It is an everything-down day. Even the news is down because commenters are being careful. 
Via Talk Markets
News headline image
Aurinia Unveils Patient Navigation Grant Program to Address Access Barriers for Individuals Living with Lupus and Lupus Nephritis
From Aurinia Pharmaceuticals Inc.
Via Business Wire
News headline image
The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron ↗
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 11) HOOKIPA Pharma Inc. (NASDAQ... 
Via Benzinga
News headline image
The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings ↗
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 10) AbbVie Inc. (NYSE: ABBV) -... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.